Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2009 Dec 11;412:e8462. doi: 10.1371/journal.pone.0008462.
Show Gene links
Show Anatomy links
Identification and developmental expression of Xenopus laevis SUMO proteases.
Wang Y, Mukhopadhyay D, Mathew S, Hasebe T, Heimeier RA, Azuma Y, Kolli N, Shi YB, Wilkinson KD, Dasso M.
???displayArticle.abstract???
SUMO proteins are small ubiquitin-related modifiers. All SUMOs are synthesized as propeptides that are post-translationally cleaved prior to conjugation. After processing, SUMOs become covalently conjugated to cellular targets through a pathway that is similar to ubiquitination. Ubiquitin like protein proteases/Sentrin specific proteases (Ulp/SENPs) mediate both processing and deconjugation of SUMOs. The action of Ulp/SENPs makes SUMOylation a highly dynamic post-translational modification. To investigate how Ulp/SENPs are regulated in a developmental context, we isolated and characterized all Ulp/SENPs in Xenopus laevis. Xenopus possess homologues of mammalian SENP3, 5, 6 and 7. All of these enzymes reacted with HA-tagged vinyl sulfone derivatives of SUMO-2 (HA-SU2-VS) but not SUMO-1 (HA-SU1-VS), suggesting that they act primarily on SUMO-2 and -3. In contrast, Xenopus possess a single member of the SENP1/SENP2 subfamily of Ulp/SENPs, most closely related to mammalian SENP1. Xenopus SENP1 reacted with HA-SU1-VS and HA-SU2-VS, suggesting that it acts on all SUMO paralogues. We analyzed the mRNA and protein levels for each of the Ulp/SENPs through development; we found that they show distinct patterns of expression that may involve both transcriptional and post-transcriptional regulation. Finally, we have characterized the developmental function of the most abundant Ulp/SENP found within Xenopus eggs, SENP3. Depletion of SENP3 using morpholino antisense oligonucleotides (morpholinos) caused accumulation of high molecular weight SUMO-2/3 conjugated species, defects in developing embryos and changes in the expression of some genes regulated by the transforming growth factor beta (TGF-beta) pathway. These findings collectively indicate that SUMO proteases are both highly regulated and essential for normal development.
???displayArticle.pubmedLink???
20041154 ???displayArticle.pmcLink???PMC2794540 ???displayArticle.link???PLoS One ???displayArticle.grants???[+]
Figure 4. SENP3 is essential for development of Xenopus laevis embryos.
(A) One cell embryos were injected with morpholinos, and subsequently harvested at Stage 39. Equal amounts of protein from Control-MO (left) or SENP3-MO (right) embryos were subjected to SDS-PAGE and Western blotting with anti-SENP3 or -actin antibodies. (B) Samples as in (A) were subjected to SDS-PAGE and Western blotting with anti-SUMO-2 and UMO-1 antibodies, as indicated. Note the substantial accumulation of high molecular weight SUMO-2-conjugated species after SENP3 knockdown, while there is essentially no change in SUMO-1 conjugates. (C) Morphological defects of SENP3-MO injected embryos were categorized according to defects in body patterning and eye development, as indicated (lower three panels). The morphology of embryos injected with Control-MO is shown in the upper panel. (D) Quantitation of morphological body deformities of SENP3-MO injected embryos. Bars indicate standard error of the mean values. p values are indicated.
Figure 1. Abundance and paralogue preference of Ulp/SENP in XEEs.(A) XEEs were incubated with buffer (left), HA-SU1-VS (middle) or HA-SU2-VS (right), and subjected to SDS-PAGE and immunoblotting with anti-HA antibodies. Free SUMO vinyl sulfones and adducts with individual SENPs are indicated. (B) XEEs were incubated with buffer (left lanes), HA-SU1-VS (middle lanes) or HA-SU2-VS (right lanes). HA-tagged proteins were purified by affinity chromatography, resolved on SDS- PAGE and visualized by Silver staining (left panel) or by immunoblotting with anti-HA antibodies (right panel). Bands recognized by the anti-HA antibodies were identified by mass spectrometry as indicated to the right of each panel. “*” indicates that SENP7 was not identified by mass spectrometry, but could be readily detected by immunoblotting with an antibody specific to SENP7. (C) In vitro translated Flag-SENP5 and Flag-SENP5-C/S were incubated with HA-SU1-VS or HA-SU2-VS. The reactions were monitored by immunoblotting with anti-HA (Upper panel) or anti-Flag (Lower panel) antibodies. “▪” indicates the position of SENP1-VS in the upper panels. Arrow indicates the position of unreacted Flag-SENP5 or Flag-SENP5-C/S.
Figure 2. RT-PCR assay showed that mRNA levels for different SENPs family proteins vary during developmental stages.Total RNA from whole animals at the indicated stages was analyzed by RT-PCR using specific primers for different SENPs and Histone H4 (control). The interval corresponding to the midblastula transition (MBT) is indicated by the arrow. UF indicates samples from unfertilized eggs, while individual stages are indicated numerically, proceeded by the abbreviation St.
Figure 3. Developmental regulation of Xenopus SENP levels.For all panels, bands corresponding to unreacted SENPs are indicated with the full name of each protein. SENPs within adducts are indicated with the following abbreviations: S1 = SENP1. S3 = SENP3. S6 = SENP6. S7 = SENP7. SUMO moieties within adducts are indicated with the following abbreviations: SU1 = SUMO-1. SU2 = SUMO-2. UF indicates samples from unfertilized eggs, while individual stages are indicated numerically, proceeded by the abbreviation St. (A) Equal amount of protein from embryos of the indicated stages were incubated with excess HA-SU2-VME. Reactions were subjected to SDS-PAGE and Western blotting with anti-HA or -Actin antibodies. “▪” indicates unidentified bands. (B) Equal amount of protein from embryos of the indicated stages were incubated with excess HA-SU2-VME (right panels) or without HA-SU2-VME (left panels). The reactions were subjected to SDS-PAGE and Western blotting with anti-SENP3, SENP5, SENP6 and SENP7 antibodies. While we did not observe detectable bands on the blot with the anti-SENP5 antibodies, in vitro translated Flag-SENP5 was clearly recognized by this antibody (additional lane in right panel). (C) Equal amount of protein from embryos of the indicated stages were incubated with excess HA-SU1-VS. Reactions were subjected to SDS-PAGE and Western blotting with anti-HA or -Actin antibodies. “▪” Indicates unidentified bands. (D) Equal amount of protein from embryos of the indicated stages were incubated with excess HA-SU2-VME (right panel), HA-SU1-VS (lower left panel) or without addition (upper left panel). The reactions were subjected to SDS-PAGE and Western blotting with anti-SENP1 antibodies.
Figure 5. Inhibition of TGF-Beta signalling by SENP3 knockdown.(A) One cell embryos were injected with morpholinos, and harvested at Stage 39. The cDNA was generated from total RNA of tadpoles. The levels of expression for the indicated mRNAs were evaluated for Control-MO or SENP3-MO populations by qRT-PCR, and normalized to that of the control gene, elongation factor-1α, and the mean of the Control-MO was set to 1. One non-regulated gene, ornithine decarboxylase (ODC), was analyzed by qRT-PCR to confirm equivalent inputs of total mRNA. For individual genes, three independent samples were analyzed, and all comparisons had p values of <0.05. (B) Schematic representation of BMP signalling. SENP3 depletion disrupts expression of BMP target genes, MSX1 and Vent1. Asterisks indicate genes that are downregulated in the absence of SENP3.
Beck,
Molecular pathways needed for regeneration of spinal cord and muscle in a vertebrate.
2003, Pubmed,
Xenbase
Beck,
Molecular pathways needed for regeneration of spinal cord and muscle in a vertebrate.
2003,
Pubmed
,
Xenbase Boyarchuk,
Bub1 is essential for assembly of the functional inner centromere.
2007,
Pubmed
,
Xenbase Broday,
The small ubiquitin-like modifier (SUMO) is required for gonadal and uterine-vulval morphogenesis in Caenorhabditis elegans.
2004,
Pubmed Bylebyl,
The SUMO isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast.
2003,
Pubmed Daniels,
Negative regulation of Smad2 by PIASy is required for proper Xenopus mesoderm formation.
2004,
Pubmed
,
Xenbase Di Bacco,
The SUMO-specific protease SENP5 is required for cell division.
2006,
Pubmed Duval,
Stability of maternal mRNA in Xenopus embryos: role of transcription and translation.
1990,
Pubmed
,
Xenbase Edelmann,
Structural basis and specificity of human otubain 1-mediated deubiquitination.
2009,
Pubmed Eisen,
Controlling morpholino experiments: don't stop making antisense.
2008,
Pubmed
,
Xenbase Gawantka,
Antagonizing the Spemann organizer: role of the homeobox gene Xvent-1.
1995,
Pubmed
,
Xenbase Geiss-Friedlander,
Concepts in sumoylation: a decade on.
2007,
Pubmed Gong,
Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3.
2006,
Pubmed Hasebe,
Evidence for a cooperative role of gelatinase A and membrane type-1 matrix metalloproteinase during Xenopus laevis development.
2007,
Pubmed
,
Xenbase Hay,
SUMO-specific proteases: a twist in the tail.
2007,
Pubmed Hay,
Role of ubiquitin-like proteins in transcriptional regulation.
2006,
Pubmed Heimeier,
The xenoestrogen bisphenol A inhibits postembryonic vertebrate development by antagonizing gene regulation by thyroid hormone.
2009,
Pubmed
,
Xenbase Hemelaar,
Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins.
2004,
Pubmed Hocking,
Expression of Bmp ligands and receptors in the developing Xenopus retina.
2007,
Pubmed
,
Xenbase Imoto,
The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway.
2004,
Pubmed Johnson,
Protein modification by SUMO.
2004,
Pubmed Kadoya,
Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of beta-catenin.
2002,
Pubmed
,
Xenbase Kang,
The type I TGF-beta receptor is covalently modified and regulated by sumoylation.
2008,
Pubmed Kerscher,
Modification of proteins by ubiquitin and ubiquitin-like proteins.
2006,
Pubmed Lee,
Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
2003,
Pubmed
,
Xenbase Li,
The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein.
2000,
Pubmed Li,
A new protease required for cell-cycle progression in yeast.
1999,
Pubmed Liang,
Regulation of Smad4 sumoylation and transforming growth factor-beta signaling by protein inhibitor of activated STAT1.
2004,
Pubmed Lima,
Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7.
2008,
Pubmed Lin,
Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4.
2003,
Pubmed Long,
Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.
2003,
Pubmed Long,
Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3).
2004,
Pubmed Mukhopadhyay,
Modification in reverse: the SUMO proteases.
2007,
Pubmed Mukhopadhyay,
SUSP1 antagonizes formation of highly SUMO2/3-conjugated species.
2006,
Pubmed Nacerddine,
The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice.
2005,
Pubmed Newport,
A major developmental transition in early Xenopus embryos: II. Control of the onset of transcription.
1982,
Pubmed
,
Xenbase Nowak,
Ubc9 regulates mitosis and cell survival during zebrafish development.
2006,
Pubmed Panse,
Formation and nuclear export of preribosomes are functionally linked to the small-ubiquitin-related modifier pathway.
2006,
Pubmed Pollet,
Insights from Xenopus genomes.
2006,
Pubmed
,
Xenbase Reverter,
A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex.
2004,
Pubmed Schwienhorst,
SUMO conjugation and deconjugation.
2000,
Pubmed Seeler,
SUMO, the three Rs and cancer.
2007,
Pubmed Shen,
The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing.
2006,
Pubmed Stade,
A lack of SUMO conjugation affects cNLS-dependent nuclear protein import in yeast.
2002,
Pubmed Talamillo,
Functional analysis of the SUMOylation pathway in Drosophila.
2008,
Pubmed Wordinger,
Bone morphogenetic proteins and their receptors in the eye.
2007,
Pubmed Xu,
Mapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1.
2005,
Pubmed Yeh,
Ubiquitin-like proteins: new wines in new bottles.
2000,
Pubmed Yukita,
XSENP1, a novel sumo-specific protease in Xenopus, inhibits normal head formation by down-regulation of Wnt/beta-catenin signalling.
2004,
Pubmed
,
Xenbase Yukita,
XSUMO-1 is required for normal mesoderm induction and axis elongation during early Xenopus development.
2007,
Pubmed
,
Xenbase Yun,
Nucleolar protein B23/nucleophosmin regulates the vertebrate SUMO pathway through SENP3 and SENP5 proteases.
2008,
Pubmed
,
Xenbase Zhang,
SUMO modification is required for in vivo Hox gene regulation by the Caenorhabditis elegans Polycomb group protein SOP-2.
2004,
Pubmed
